Option Care Health, Inc. (OPCH)

Market Cap	5.82B
Revenue (ttm)	5.00B
Net Income (ttm)	211.82M
Shares Out	165.32M
EPS (ttm)	1.23
PE Ratio	28.61
Forward PE	26.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,242,177
Open	35.03
Previous Close	34.71
Day's Range	34.89 - 35.44
52-Week Range	21.39 - 35.44
Beta	1.33
Analysts	Buy
Price Target	33.00 (-6.22%)
Earnings Date	Apr 22, 2025

About OPCH

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic art...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: John Rademacher
• Employees: 8,088
• Stock Exchange: NASDAQ
• Ticker Symbol: OPCH
• Website: https://www.optioncarehealth.com

Financial Performance

In 2024, Option Care Health's revenue was $5.00 billion, an increase of 16.17% compared to the previous year's $4.30 billion. Earnings were $211.82 million, a decrease of -20.69%.

Analyst Forecast

According to 7 analysts, the average rating for OPCH stock is "Buy." The 12-month stock price forecast is $33.0, which is a decrease of -6.22% from the latest price.

Price Target

$33.0

(-6.22% downside)

Analyst Consensus: Buy